Excellent response to olaparib in metastatic HR-positive, HER2-negative breast cancer with BRIP1 mutation

D. Kwapisz, B. Verret, C. Garcia, F. André

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Access to Document

@article{c2ef9b7bcc0246199bca4552185997f2,

title = "Excellent response to olaparib in metastatic HR-positive, HER2-negative breast cancer with BRIP1 mutation",

author = "D. Kwapisz and B. Verret and C. Garcia and F. Andr{\'e}",

year = "2023",

month = mar,

day = "1",

doi = "10.1016/j.annonc.2023.01.012",

language = "English",

volume = "34",

pages = "315--318",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "3",

}

TY - JOUR

T1 - Excellent response to olaparib in metastatic HR-positive, HER2-negative breast cancer with BRIP1 mutation

AU - Kwapisz, D.

AU - Verret, B.

AU - Garcia, C.

AU - André, F.

PY - 2023/3/1

Y1 - 2023/3/1

UR - http://www.scopus.com/inward/record.url?scp=85148345918&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2023.01.012

DO - 10.1016/j.annonc.2023.01.012

M3 - Letter

C2 - 36813328

AN - SCOPUS:85148345918

SN - 0923-7534

VL - 34

SP - 315

EP - 318

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -